Rapid PR & Expert Commentary
Independent news publications cover the stories shaping your industry. Submit your expert commentary and get cited, with first results in minutes.
Submit Expert Commentary for PR →Add your own news briefRecord your thoughts or type. Review your precise quote before submitting.
Pharmaceuticals PR works best when expertise answers a real reader question. This page brings together news opportunities relevant to pharma companies and pharmacy operators. Focus your commentary on medicine development, supply reliability and patient information. Choose a story below, or submit a brief based on your own informed observations.
Published 2026-10-12
The University of Maryland, Baltimore reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in pharmaceuticals?
Published 2026-10-12
BioSpace reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in pharmaceuticals?
Published 2026-10-12
Yahoo Finance reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in pharmaceuticals?
Published 2026-10-12
Bayer announced a planned $2.2 billion modular pharmaceutical manufacturing campus in New Albany, Ohio, intending to combine drug-substance and drug-product production with advanced digital and automation technologies. The company said the first module would focus on drug-substance manufacturing (operational in 2031) and a second module for drug-product manufacturing would follow in 2034, with expected construction and permanent job counts cited.
Consider whether this expansion could affect regional supply chain capacity, competition for skilled manufacturing labor, and demand for CDMO services.
Consider: What operational or workforce partnerships should pharmaceutical manufacturers consider to support a multi‑module, automated campus like Bayer’s planned site?
Published 2026-10-12
Biz New Orleans reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in pharmaceuticals?
Evergreen perspective
Share practical expertise grounded in the linked industry sources and your own experience.
Consider: What should customers understand before making an important decision?
Evergreen perspective
Share practical expertise grounded in the linked industry sources and your own experience.
Consider: Which priorities will matter most over the coming years, and why?
Make your expertise useful
Explain what a development means, who it affects and what they should consider next. Your commentary can be recorded or typed, then reviewed before submission.
Who can contribute: Pharma companies; pharmacy operators.
For a story affecting pharmaceuticals, explain one practical consequence connected to medicine development. Identify the audience affected, the decision they face and what your professional experience helps them understand. Include a specific example you can substantiate; avoid turning a personal observation into a claim about the entire industry.
Use examples only when they reflect your own informed view. You can also bring your own announcement or news brief.
Explore the PR Guide →
Your free trial starts automatically. No license key is needed yet.